The impact of obesity on male fertility

 

INTRODUCTION

The prevalence of obesity worldwide has doubled since 1980; 65% of the global population now live in countries where overweight and obesity results in more morbidity than underweight, while the combined medical costs associated with obesity have increased by an estimated £2 billion/year.1–3 In examining the impact of overweight and obesity on male reproductive functioning it needs to be appreciated that fertility is a complex multifactorial process involving the female partner as well and, therefore, while robust endpoints such as pregnancy and live birth are the key outcomes, surrogate endpoints such as analysis of spermatogenesis are often required. Furthermore, obesity affects male fertility via multiple mechanisms including obesity-associated hypogonadism, its impacts on sperm production and function and its atherogenic effect on peripheral vasculature which may also cause erectile dysfunction.4,5

OBESITY AND HYPOGONADISM

Male obesity is associated with hypogonadism. This may be as a result of a combination of hypogonadotrophic hypogonadism, a reduction in sex hormone binding globulin (SHBG) production by the liver, and greater adipocyte aromatase activity resulting in an increase in the conversion of testosterone to estradiol leading to altered hypothalamic and pituitary negative feedback. The EMAS analysis of older men (ages 40 to 80) confirms the substantial effect of increasing BMI on total testosterone, free testosterone, and SHBG at all ages.6 A relationship between degree of obesity and effect is very apparent. A meta-analysis of these relationships confirmed the clear impact of increasing BMI on low testosterone, low free testosterone, and SHBG, though study results of the effects on estradiol have been much less consistent.7 Most studies moreover did not find any effect on LH levels, although an early study suggested a reduced LH pulse amplitude but not pulse frequency in obese men.8 This may reflect the now well-recognised impact of energy sensing pathways on the kisspeptin/neurokinin B pathways in the hypothalamus, which drive GnRH pulsatile secretion.9

Longitudinal data from the EMAS study provide evidence of the impact on weight gain or loss on male reproductive endocrinology. Importantly, these data show that weight loss is associated with rises in total testosterone, free testosterone, and SHBG, the latter exhibiting the clearest size effect relationship. The rise in SHBG with modest weight loss therefore tends to obscure any effect on free testosterone until weight loss is more substantial. These studies also indicate a rise in LH with more marked weight loss.10,11 Overall, the abovementioned analyses therefore point to the potential benefit of weight loss measures in hypogonadal obese men, and indeed studies assessing lifestyle change and bariatric surgery confirm the beneficial effects of weight loss on male reproductive function. A meta-analysis of 24 studies also pointed to a relationship between reductions in BMI and rise in testosterone, with the testosterone rise being greater in younger and more obese men.12

OBESITY, SPERMATOGENESIS, AND FERTILITY

While results demonstrating the endocrine effects of obesity on male reproductive function are largely robust, those indicating effects on fertility, and particularly on spermatogenesis are less consistent. Any analysis of the impact of the rising prevalence of obesity also needs to give serious consideration to the known background changes in male fertility that have occurred over the past few decades. Registry-based studies indicate US fertility rates (births/1000 men) have declined from 57 in 1980 to 45.8 in 2013,13 and in Denmark the number of offspring per man at age 45 dropped from 1.9 to 1.7 between 1990 and 2005,14 an effect partially compensated for by increasing rates of IVF.14 In many countries, the prevalence of male reproductive disorders has been steadily rising, this is most robustly demonstrated in the rising incidence of testicular cancers.15 Concerns over declining spermatogenesis are more controversial but appear well established in some,16,17 if not all, populations.18

Evidence for an association between obesity and fertility rates comes from epidemiological studies examining correlations between BMI and fertility, and also from comparisons of sperm counts in obese and normal-weight men. Epidemiological studies have consistently demonstrated an impact of obesity on male reproductive function. The Danish National Birth Cohort reported in 2007 an analysis of 47,835 couples. Increasing BMI in males was associated with subfertility (time to pregnancy of >12months) with an adjusted odds ratio (AOR) (95% confidence interval) of 1.53 (1.32-1.77) in obese men (BMI >30 kg/m2), an effect which increased to 2.75 (2.27-3.30) where the female was also obese.19 Comparable data were obtained in the Norwegian Mother and Child Cohort of 26,303 planned pregnancies where the adjusted OR for infertility at 12 months was 1.2 (1.04-1.38) in overweight men and 1.36 (1.13-1.63) for obese men relative to those of normal weight, likely a conservative estimate given that couples failing to conceive were excluded from the analysis.20 The results were similar when only couples where the female had a normal BMI were analysed. Data from the Agricultural Health Study in the United States also showed increasing BMI to be associated with infertility at 12 months: in this study, a 3kg/m2 increase in BMI was associated with increased risk of subfertility of 1.21 (1.07-1.38).21 All of these studies used self-reported weight and height and collected the data retrospectively; the Scandinavian studies also excluded unplanned pregnancies, all of which factors may have affected the accuracy of the results, although the data are remarkably consistent.

Studies assessing the impact of obesity on spermatogenesis have been less consistent. The major confounding factor in many studies is that samples are often drawn from populations presenting to infertility centres, resulting in bias. An exception is a study of military recruits from Denmark where men with a BMI of over 25kg/m2 showed 21% and 23.9% reductions in sperm concentration and total sperm count, respectively.22 Underweight men (BMI <20kg/m2) also showed a reduced sperm concentration and total sperm count. In neither group were percentages of normal or motile spermatozoa different.22 This analysis included a large number of individuals (1,558); however, their median age was only 19. An American cohort of 468 men, also recruited outside a fertility setting, found BMI and waist circumference to correlate only with ejaculate volume and not with any other sperm parameters, although the number of recruits with BMI <25 (the reference group) was relatively small (n=83).4 A meta-analysis in 2010 concluded that there was no evidence for a relationship between BMI and sperm concentration or total sperm count,7 with only 5 of 31 studies identified being able to be pooled for analysis. A subsequent larger meta-analysis, in which 21 studies reporting on over 13,000 men were included, did however find evidence of a significant impact on spermatogenesis, with OR for oligospermia or azoospermia of 1.11 (1.01-1.21) for overweight and 1.28 (1.06-1.55) for obese men, rising to 2.04 (1.59-2.62) for morbidly obese men.23 There was strong heterogeneity between studies, impacted upon by multiple factors, for example, operator variability, time of abstinence, and time of year that the sample was taken.

Evidence of abnormal sperm function derives from analyses of IVF and ICSI outcomes in obese males where the live birth rates per embryo transfer are reduced in obese men when compared to those of healthy BMI.24,25 The suggestion of an increased risk of pregnancy loss after assisted conception26embryo development and pregnancy, and live birth outcomes after assisted reproductive technology (ART is intriguing and may also indicate abnormal sperm function. One potential mechanism possibly accounting for this is through increased sperm DNA fragmentation. Analysis of chromatin integrity suggests that both overweight and obese men show increased sperm chromatin damage.4,7,27,28 Methods for assessing sperm DNA integrity however remain debated.29 While an initial meta-analysis (not addressing BMI) suggested that sperm DNA damage was associated with increased pregnancy loss, a more recent update from the same group failed to find a consistent link to embryo quality and/or development.30,31 A further factor of relevance to disrupted sperm function in obese men is the presence of reactive oxygen species (ROS), an indicator of perturbed mitochondrial function.32 Increased ROS were present in the semen of obese men, which appeared to originate from macrophages.33 In rodent studies, high fat diet exposure also increased reactive oxygen species in sperm,34,35 an effect which also perturbed embryonic development.36

IS THERE A TRANSGENERATIONAL IMPACT OF PATERNAL OBESITY?

Epidemiological and experimental studies suggest that paternal obesity may also impact on the metabolic health of offspring and grand-offspring. Offspring of obese parents are more likely to be obese and suffer from adverse metabolic health, with some studies showing the strongest effect exerted by paternal obesity.37,38 Data collected in Överkalix at the end of the 19thand in the early 20th century in Sweden suggest that paternal nutrition impacts on mortality and risk of cardiovascular disease in grandsons.39 However, comparison of multiple studies does not provide conclusive evidence that there is a clear maternal or paternal effect of obesity that can be differentiated; rather, the conclusion is that it is difficult to control for the presence of environmental and genetic confounding, which thus makes interpretation complex.38 For this reason, experimental studies in which postnatal and genetic factors can be controlled have been useful to determine if effects can be transmitted from father to offspring after which the potential mechanisms may be investigated. Evidence showing the transmission of diet-induced phenotypes through the male line is supportive of the concept that transmission may be mediated by non-genetic inheritance,40–44 with some evidence suggesting a perturbed ‘epigenome’ in the sperm.40–44 These studies are summarised in the Table. It should be borne in mind, however, that paternal behaviour and the constituents of semen may also influence maternal behaviour and/or pre-implantation development and thus might also have a part to play.45–48

There are few studies addressing whether weight loss might improve fertility. However, an abstract presented at ENDO 2015 indicates that in a cohort of obese men, those whose partners conceived had lost more weight, and significant independent predictors of pregnancy were losing weight, eating more breakfasts weekly, and greater consumption of fruit and vegetables.49 Studies in mice also provide evidence that sperm parameters and metabolic health in offspring can be improved by a switch from a high-fat to a low-fat diet, an effect additionally enhanced by exercise.50,51 A small study of men undergoing bariatric surgery for obesity found improvement in hormonal measures but no change in sperm parameters 2 years following the intervention.52 This is in contrast to case series which identified a fall in already perturbed sperm counts following bariatric surgery, with incomplete recovery at 2 years post-surgery.23,53 In contrast, diet and exercise induced weight loss may improve sperm parameters.54

CONCLUSION

Obesity has multifactorial effects on male reproductive function, with clear evidence of endocrine disturbance in the form of hypogonadotropic hypogonadism, probably accompanied by hyperestrogenemia (Figure). The epidemiologic evidence for reduced fertility also appears clear, but the mechanisms for this, also likely to be multifactorial, are less apparent. There is some evidence of abnormal Sertoli cell function/spermatogenesis, but not all studies have found this. These effects may be accompanied by reduced coital frequency and erectile dysfunction in some men. Importantly, however, evidence is starting to emerge that many, if not all, of these effects are reversible. Knowledge is also accumulating about the impact of obesity on spermatogenesis and its potential implications for subsequent generations.

Figure. Factors contributing to reduced fertility in obese men.

REFERENCES

  • 1. Ng M, Fleming T, Robinson M, et al, 2014 Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384: 766-781.
  • 2. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M, 2011 Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378: 815-825. 3. WHO. WHO | Obesity and overweight [Internet]. WHO2014 [cited 2014 May 21]; Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
  • 4. Eisenberg ML, Kim S, Chen Z, Sundaram R, Schisterman EF, Buck Louis GM, 2014 The relationship between male BMI and waist circumference on semen quality: data from the LIFE study. Hum Reprod Oxf Engl 29: 193-200.
  • 5. Kaya E, Sikka SC, Gur S, 2015 A Comprehensive Review of Metabolic Syndrome Affecting Erectile Dysfunction. J Sex Med 12: 856-875.
  • 6. Wu FCW, Tajar A, Pye SR, Silman AJ, et al, 2008 Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93: 2737-2745.
  • 7. MacDonald AA, Herbison GP, Showell M, Farquhar CM, 2010 The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis. Hum Reprod Update 16: 293-311.
  • 8. Vermeulen A, Kaufman JM, Deslypere JP, Thomas G, 1993 Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab 76: 1140-1146.
  • 9. Roa J, Tena-Sempere M, 2014 Connecting metabolism and reproduction: roles of central energy sensors and key molecular mediators. Mol Cell Endocrinol 397: 4-14. 10. Camacho EM, Huhtaniemi IT, O’Neill TW, et al, 2013 Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol Eur Fed Endocr Soc 168: 445-455.
  • 11. Rastrelli G, Carter EL, Ahern T, et al, 2015 Development of and Recovery from Secondary Hypogonadism in Ageing Men: Prospective Results from the EMAS. J Clin Endocrinol Metab 100 : 3172-3182.
  • 12. Corona G, Rastrelli G, Monami M, et al, 2013 Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol Eur Fed Endocr Soc 168: 829-843.
  • 13. Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews TJ, 2015 Births: final data for 2013. Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst 64:1-65.
  • 14. Priskorn L, Holmboe SA, Jacobsen R, Jensen TK, Lassen TH, Skakkebaek NE, 2012 Increasing trends in childlessness in recent birth cohorts - a registry-based study of the total Danish male population born from 1945 to 1980. Int J Androl 35: 449-455.
  • 15. Le Cornet C, Lortet-Tieulent J, Forman D, et al, 2014 Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer 50: 831-839.
  • 16. Rolland M, Moal JL, Wagner V, Royère D, Mouzon JD, 2012 Decline in semen concentration and morphology in a sample of 26 609 men close to general population between 1989 and 2005 in France. Hum Reprod 28: 462-470.
  • 17. Romero-Otero J, Medina-Polo J, García-Gómez B, et al, 2015 Semen Quality Assessment in Fertile Men in Madrid During the Last 3 Decades. Urology 85: 1333-1338.
  • 18. Jørgensen N, Joensen UN, Jensen TK, et al, 2012 Human semen quality in the new millennium: a prospective cross-sectional population-based study of 4867 men. BMJ Open 2:e000990.
  • 19. Ramlau-Hansen CH, Thulstrup AM, Nohr EA, Bonde JP, Sørensen TIA, Olsen J, 2007 Subfecundity in overweight and obese couples. Hum Reprod 22: 1634-1637.
  • 20. Nguyen RHN, Wilcox AJ, Skjaerven R, Baird DD, 2007 Men’s body mass index and infertility. Hum Reprod Oxf Engl 22: 2488-2493.
  • 21. Sallmén M, Sandler DP, Hoppin JA, Blair A, Baird DD, 2006 Reduced fertility among overweight and obese men. Epidemiol Camb Mass 17: 520-523.
  • 22. Jensen TK, Andersson A-M, Jørgensen N, et al, 2004 Body mass index in relation to semen quality and reproductive hormonesamong 1,558 Danish men. Fertil Steril 82: 863-870.
  • 23. Sermondade N, Massin N, Boitrelle F, et al, 2012 Sperm parameters and male fertility after bariatric surgery: three case series. Reprod Biomed Online 24: 206-210.
  • 24. Colaci DS, Afeiche M, Gaskins AJ, et al, 2012 Men’s body mass index in relation to embryo quality and clinical outcomes in couples undergoing in vitro fertilization. Fertil Steril 98: 1193-9.e1.
  • 25. Moragianni VA, Jones S-ML, Ryley DA, 2012 The effect of body mass index on the outcomes of first assisted reproductive technology cycles. Fertil Steril 98: 102-108.
  • 26. Bakos HW, Henshaw RC, Mitchell M, Lane M, 2011 Paternal body mass index is associated with decreased blastocyst development and reduced live birth rates following assisted reproductive technology. Fertil Steril 95: 1700-1704.
  • 27. Fariello RM, Pariz JR, Spaine DM, Cedenho AP, Bertolla RP, Fraietta R, 2012 Association between obesity and alteration of sperm DNA integrity and mitochondrial activity. BJU Int 110: 863-867.
  • 28. Kort HI, Massey JB, Elsner CW, et al, 2006 Impact of Body Mass Index Values on Sperm Quantity and Quality. J Androl 27: 450-452.
  • 29. Barratt CLR, Aitken RJ, Björndahl L, et al, 2010 Sperm DNA: organization, protection and vulnerability: from basic science to clinical applications--a position report. Hum Reprod Oxf Engl 25: 824-838.
  • 30. Zini A, Boman JM, Belzile E, Ciampi A, 2008 Sperm DNA damage is associated with an increased risk of pregnancy loss after IVF and ICSI: systematic review and meta-analysis. Hum Reprod Oxf Engl 23: 2663-2668.
  • 31. Zini A, Jamal W, Cowan L, Al-Hathal N, 2011 Is sperm DNA damage associated with IVF embryo quality? A systematic review. J Assist Reprod Genet 28: 391-397.
  • 32. Aitken RJ, Smith TB, Jobling MS, Baker MA, De Iuliis GN, 2014 Oxidative stress and male reproductive health. Asian J Androl 16: 31-38.
  • 33. Tunc O, Bakos HW, Tremellen K, 2011 Impact of body mass index on seminal oxidative stress. Andrologia 43: 121-128.
  • 34. Fullston T, Palmer NO, Owens JA, Mitchell M, Bakos HW, Lane M, 2012 Diet-induced paternal obesity in the absence of diabetes diminishes the reproductive health of two subsequent generations of mice. Hum Reprod 27: 1391-1400.
  • 35. Fullston T, McPherson NO, Owens JA, Kang WX, Sandeman LY, Lane M, 2015 Paternal obesity induces metabolic and sperm disturbances in male offspring that are exacerbated by their exposure to an “obesogenic” diet. Physiol Rep 3:e12336.
  • 36. Lane M, McPherson NO, Fullston T, et al, 2014 Oxidative stress in mouse sperm impairs embryo development, fetal growth and alters adiposity and glucose regulation in female offspring. PloS One 9:e100832.
  • 37. Jääskeläinen A, Pussinen J, Nuutinen O, et al, 2011 Intergenerational transmission of overweight among Finnish adolescents and their parents: a 16-year follow-up study. Int J Obes 35: 1289-1294.
  • 38. Patro B, Liber A, Zalewski B, Poston L, Szajewska H, Koletzko B, 2013 Maternal and Paternal Body Mass Index and Offspring Obesity: A Systematic Review. Ann Nutr Metab 63: 32-41.
  • 39. Kaati G, Bygren LO, Pembrey M, Sjöström M, 2007 Transgenerational response to nutrition, early life circumstances and longevity. Eur J Hum Genet 15: 784-790.
  • 40. Anderson LM, Riffle L, Wilson R, Travlos GS, Lubomirski MS, Alvord WG, 2006 Preconceptional fasting of fathers alters serum glucose in offspring of mice. Nutrition 22: 327-331.
  • 41. Carone BR, Fauquier L, Habib N, et al, 2010 Paternally Induced Transgenerational Environmental Reprogramming of Metabolic Gene Expression in Mammals. Cell 143: 1084-1096.
  • 42. Fullston T, Teague EMCO, Palmer NO, et al, 2013 Paternal obesity initiates metabolic disturbances in two generations of mice with incomplete penetrance to the F2 generation and alters the transcriptional profile of testis and sperm microRNA content. FASEB J 27: 4226-4243.
  • 43. Ng S-F, Lin RCY, Laybutt DR, Barres R, Owens JA, Morris MJ, 2010 Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring. Nature 467: 963-966.
  • 44. Öst A, Lempradl A, Casas E, et al, 2014 Paternal Diet Defines Offspring Chromatin State and Intergenerational Obesity. Cell 159: 1352-1364.
  • 45. Binder NK, Sheedy JR, Hannan NJ, Gardner DK, 2015 Male obesity is associated with changed spermatozoa Cox4i1 mRNA level and altered seminal vesicle fluid composition in a mouse model. Mol Hum Reprod 21: 424-434.
  • 46. Bromfield JJ, Schjenken JE, Chin PY, Care AS, Jasper MJ, Robertson SA, 2014 Maternal tract factors contribute to paternal seminal fluid impact on metabolic phenotype in offspring. Proc Natl Acad Sci 111: 2200-2205.
  • 47. Crean AJ, Kopps AM, Bonduriansky R, 2014 Revisiting telegony: offspring inherit an acquired characteristic of their mother’s previous mate. Ecol Lett 17: 1545-1552. 48. Curley JP, Mashoodh R, Champagne FA, 2011 Epigenetics and the origins of paternal effects. Horm Behav 59: 306-314.
  • 49. Belan M, Duval K, Jean-Denis F, et al, 2015 Impacts of Lifestyle and Anthropometric Changes in Male Partners of Obese Infertile Women on Couples’ Fertility - Preliminary Results from a Cohort Study. San Diego: 2015.
  • 50. McPherson NO, Bakos HW, Owens JA, Setchell BP, Lane M, 2013 Improving Metabolic Health in Obese Male Mice via Diet and Exercise Restores Embryo Development and Fetal Growth. PLoS ONE 8:e71459.
  • 51. McPherson NO, Owens JA, Fullston T, Lane M, 2015 Preconception diet or exercise intervention in obese fathers normalizes sperm microRNA profile and metabolic syndrome in female offspring. Am J Physiol - Endocrinol Metab 308: E805-821.